Occurrence of thymic pathology in two families. Is familial screening justified?

Submitted: February 3, 2018
Accepted: August 1, 2018
Published: September 4, 2018
Abstract Views: 884
PDF: 567
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


The familial occurrence of thymic pathology, even though rare, is widely reported in the literature and mainly concerns cases of familial autoimmune myasthenia gravis. Other less frequent cases of familial occurrence of thymoma, thymic carcinoid and thymic hyperplasia have been described. It seems that the familial occurrence is poorly recorded and thus its prevalence is underestimated. We report two families whose members presented different forms of thymic pathology and discuss the necessity of screening programs in family members of patients presenting a thymic lesion.



PlumX Metrics


Download data is not yet available.


How to Cite

Moraitis, Sotirios D., Apostolos C. Agrafiotis, Amalia Kapranou, Marina Constantinou, Konstantinos Kanakakis, and Panagiotis Hountis. 2018. “Occurrence of Thymic Pathology in Two Families. Is Familial Screening Justified?”. Monaldi Archives for Chest Disease 88 (3). https://doi.org/10.4081/monaldi.2018.913.